Please note

Due to the recent spike in Covid-19 cases, we are no longer able to entertain walk-in visits to our headquarters or any of our facilities.

Regkirona Vial 60 Mg Solution

Dexa Medica

Ingredients in every sustained-release tablet

Regdanvimab 60 mg

Each package contains

1 vial of 16 ml

Dosage form

Solution for infusion

Dosage formSolution for infusion

Flavour

None

W.H.O. classification

A.T.C. Level 1

Anatomical Main group

A - Alimentary tract and metabolism

A.T.C. Level 2

Therapeutic subgroup

A10 - Drugs Used in Diabetes

A.T.C. Level 3

Pharmacological subgroup

A10B - Blood Glucose Lowering Drugs; excl. Insulins

Available in

Indonesia

Warnings

Alcohol

CONSULT YOUR DOCTORSafety of this item for use with alcohol has not been established. Please consult your doctor.

Machinery

CONSULT YOUR DOCTORSafety of this item for use while operating heavy machinery has not been established. Please consult your doctor.

Pregnancy

CAUTIONThis item may not be safe for use during pregnancy. Use with caution and after consultation with your doctor.

Lactation

CONSULT YOUR DOCTORSafety of this item for use with alcohol has not been established. Please consult your doctor.

Indication

Under the EUA, regdanvimab is indicated for the treatment of confirmed Covid-19 in adult patients that do not require supplemental oxygen and who are at high risk for progressing to severe Covid-19.

Dosage

65 YEARS OLD AND ABOVE
No dose adjustment of regdanvimab is required in elderly patients.

18 YEARS OLD AND ABOVE
The recommended dosage of regdanvimab is a single intravenous (IV) infusion of 40
mg/kg.
Treatment should be initiated as soon as possible after diagnosis, and not later than 7 days
after the onset of symptoms.

0-17 YEARS OLD AND ABOVE
The safety and efficacy of regdanvimab in pediatric patients have not yet been established. No data
are available